Home | Welcome to Contract Pharma   
Last Updated Saturday, August 2 2014
Print

Breaking News

November 15, 2013
To begin commercial production in 2017  Read More »
November 15, 2013
WuXi's manufacturing facilities pass FDA inspection  Read More »
November 14, 2013
Expands global clinical supply network   Read More »
November 14, 2013
Gains Antibody Drug Conjugation Technology  Read More »
November 14, 2013
Caforio, Bancroft, Gordon, and Cazala take on new roles  Read More »
November 14, 2013
Disruption not expected to impact Tesamorelin shipment  Read More »
November 14, 2013
To invest $750M in Indianapolis, PR, France and China  Read More »
November 14, 2013
Bomba brings 20 years of experience  Read More »
November 14, 2013
Driven by new technologies, improved outcomes, and small molecule patent losses  Read More »
November 14, 2013
Expands specialized research services  Read More »
November 13, 2013
Will leverage Nanocyclix platform to develop therapies for neurodegenerative diseases   Read More »
November 13, 2013
Zimmer brings 30 years of industry experience  Read More »
November 13, 2013
Allows visualization, analysis and reporting on lab data in real time  Read More »
Gil Roth
November 13, 2013
Discovery Labs, Fibrogen, Pluristem, RXi, Tekmira, Vivus, Zysis  Read More »
November 12, 2013
Gains carbohydrate synthesis technology platform  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On